Prostate Biopsy Characteristics: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task...

Area of Science:

• Urology
• Oncology
• Public Health

Background:

• The 2012 United States Preventive Services Task Force (USPSTF) issued recommendations against prostate-specific antigen (PSA) screening for prostate cancer (PCa).
• These recommendations aimed to reduce overdiagnosis and overtreatment of PCa.
• The impact of these recommendations on PCa detection rates and disease characteristics remains a critical area of study.

Purpose of the Study:

• To compare PCa characteristics diagnosed by prostate biopsy (Pbx) before and after the 2012 USPSTF recommendations.
• To analyze changes in biopsy rates, cancer detection, and grade distribution following the USPSTF guidelines.

Main Methods:

• Retrospective comparative analysis of 402 PCa patients diagnosed from 2010-2012 (Group A, pre-USPSTF) and 552 PCa patients diagnosed from 2015-2017 (Group B, post-USPSTF).
• Data collected included patient demographics, PSA levels, Gleason sum score (GSS), and digital rectal examination (DRE) findings.
• Statistical analysis was performed to compare PCa characteristics between the two groups.

Main Results:

• A 30% reduction in annual prostate biopsy rates was observed post-USPSTF recommendations (Group A: 567/year vs. Group B: 398/year).
• Despite fewer biopsies, the annual PCa detection rate increased by 37.3% (Group A: 134/year vs. Group B: 184/year).
• The proportion of high-grade PCa (GSS 7-10) increased by 8.6% (Group A: 51.5% vs. Group B: 60.1%).

Conclusions:

• The 2012 USPSTF recommendations led to a significant decrease in prostate biopsy procedures.
• Concurrently, there was an increase in the detection rate of prostate cancer, including a higher proportion of high-grade cancers.
• These findings suggest a shift towards detecting more advanced PCa after the implementation of the USPSTF guidelines.